JP2014525233A5 - - Google Patents

Download PDF

Info

Publication number
JP2014525233A5
JP2014525233A5 JP2014524371A JP2014524371A JP2014525233A5 JP 2014525233 A5 JP2014525233 A5 JP 2014525233A5 JP 2014524371 A JP2014524371 A JP 2014524371A JP 2014524371 A JP2014524371 A JP 2014524371A JP 2014525233 A5 JP2014525233 A5 JP 2014525233A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
antibody
acid sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014524371A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014525233A (ja
JP6277125B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/065505 external-priority patent/WO2013020995A1/en
Publication of JP2014525233A publication Critical patent/JP2014525233A/ja
Publication of JP2014525233A5 publication Critical patent/JP2014525233A5/ja
Application granted granted Critical
Publication of JP6277125B2 publication Critical patent/JP6277125B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014524371A 2011-08-09 2012-08-08 ホスホリルコリンに対する新規抗体 Expired - Fee Related JP6277125B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161521593P 2011-08-09 2011-08-09
US61/521,593 2011-08-09
PCT/EP2012/065505 WO2013020995A1 (en) 2011-08-09 2012-08-08 New antibodies against phosphorylcholine

Publications (3)

Publication Number Publication Date
JP2014525233A JP2014525233A (ja) 2014-09-29
JP2014525233A5 true JP2014525233A5 (enExample) 2015-10-01
JP6277125B2 JP6277125B2 (ja) 2018-02-07

Family

ID=46679261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014524371A Expired - Fee Related JP6277125B2 (ja) 2011-08-09 2012-08-08 ホスホリルコリンに対する新規抗体

Country Status (28)

Country Link
US (3) US9803028B2 (enExample)
EP (1) EP2742068B1 (enExample)
JP (1) JP6277125B2 (enExample)
KR (1) KR101947758B1 (enExample)
CN (1) CN104039832B (enExample)
AR (1) AR087485A1 (enExample)
AU (1) AU2012293646B2 (enExample)
BR (1) BR112014002929A8 (enExample)
CA (1) CA2843921A1 (enExample)
CY (1) CY1121950T1 (enExample)
DK (1) DK2742068T3 (enExample)
ES (1) ES2732838T3 (enExample)
HK (1) HK1200852A1 (enExample)
HR (1) HRP20190988T1 (enExample)
HU (1) HUE045163T2 (enExample)
LT (1) LT2742068T (enExample)
MX (1) MX364425B (enExample)
PL (1) PL2742068T3 (enExample)
PT (1) PT2742068T (enExample)
RS (1) RS58986B1 (enExample)
RU (1) RU2654584C2 (enExample)
SG (1) SG2014009344A (enExample)
SI (1) SI2742068T1 (enExample)
SM (1) SMT201900366T1 (enExample)
TR (1) TR201909072T4 (enExample)
TW (1) TWI707873B (enExample)
WO (1) WO2013020995A1 (enExample)
ZA (1) ZA201400665B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014002929A8 (pt) * 2011-08-09 2021-09-28 Athera Biotechnologies Ab Novos anticorpos contra fosforilcolina
JP6277126B2 (ja) 2011-08-09 2018-02-07 アセラ・バイオテクノロジーズ・アーベー ホスホリルコリン（ｐｃ）および／またはｐｃコンジュゲートに結合する抗体
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
WO2016145128A1 (en) 2015-03-09 2016-09-15 Caris Science, Inc. Oligonucleotide probes and uses thereof
IL318703A (en) 2015-06-29 2025-03-01 Caris Science Inc Therapeutic oligonucleotides
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
EP4680632A2 (en) 2023-03-17 2026-01-21 Oxitope Pharma B.V. Anti-phosphocholine antibodies and methods of use thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402664A1 (fr) 1977-09-07 1979-04-06 Agronomique Inst Nat Rech Produits de couplage phosphorylcholine, composes amines procede d'obtention et applications
US5955584A (en) 1986-03-31 1999-09-21 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
DE3751182T2 (de) 1986-08-06 1995-10-26 Scripps Clinic Res Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden.
JPH02188532A (ja) 1989-01-17 1990-07-24 Otsuka Pharmaceut Co Ltd リポソームワクチン
AU5522390A (en) 1989-04-19 1990-11-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for removing c-reactive protein and anti-phosphorylcholine antibodies from biological fluids
JP3283041B2 (ja) 1990-07-13 2002-05-20 学校法人藤田学園 人工抗体
WO1992010203A1 (en) 1990-12-10 1992-06-25 Alving Carl R A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
RU2014609C1 (ru) * 1991-06-06 1994-06-15 Московский институт тонкой химической технологии им.М.В.Ломоносова Способ определения белков, специфичных к фосфорилхолину
JPH07504817A (ja) 1992-03-03 1995-06-01 ザ ロックフェラー ユニヴァーシティ Ｂ２９（Ｉｇ‐βまたはＩｇ−γ）を含むレセプタ複合体およびその利用
AU5959494A (en) 1992-12-29 1994-07-19 Entremed, Inc Vaccines against sterols
WO1994018955A1 (en) 1993-02-22 1994-09-01 Alza Corporation Compositions for oral delivery of active agents
US5455032A (en) 1993-07-29 1995-10-03 The United States Of America As Represented By The Department Of Health And Human Services Use of phosphocholine hapten conjugates in vaccines
US6375925B1 (en) 1996-11-08 2002-04-23 The Regents Of The University Of California Methods and reagents for non-invasive imaging of atherosclerotic plaque
WO1998021581A1 (en) 1996-11-08 1998-05-22 The Regents Of The University Of California Methods and reagents for non-invasive imaging of atherosclerotic plaque
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US20040185039A1 (en) 2002-08-30 2004-09-23 Heinz Kohler Therapeutic applications of noncovalent dimerizing antibodies
US6300308B1 (en) 1997-12-31 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions for inducing autoimmunity in the treatment of cancers
DE69911417T2 (de) 1998-07-03 2004-06-17 Athera Biotechnologies Ab Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose
SE9802402D0 (sv) 1998-07-03 1998-07-03 Karolinska Innovations Ab Method of diagnosing cardiovascular disease and early atherosclerosis
MXPA02004244A (es) 1999-10-26 2002-11-04 Univ California Reactivos y metodos para el diagnostico, la formacion de imagenes y el tratamiento del padecimiento de la ateroesclerosis..
SE0000855D0 (sv) 2000-03-15 2000-03-15 Karolinska Innovations Ab Antigenic composition useful as a vaccine against atherosclerosis
WO2001088547A2 (en) 2000-05-12 2001-11-22 The Regents Of The University Of California Standardized oxidized ldl assay
DE10041515A1 (de) 2000-08-24 2002-03-14 Gerold Schuler Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
SE0103754L (sv) 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20070122419A1 (en) 2003-04-11 2007-05-31 The Regents Of The University Of California Methods and compositions for treating atherosclerosis
DE602005023428D1 (de) * 2004-04-15 2010-10-21 Athera Biotechnologies Ab Verfahren zur Feststellung der Gefahren von ischemischen Herzgefässerkrankungen mit PhosphorylcholinKonjugaten
AU2005271523B2 (en) 2004-08-03 2011-09-15 Dyax Corp. hk1-binding proteins
WO2007084253A2 (en) 2005-11-28 2007-07-26 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
AU2006235507B2 (en) 2005-04-12 2012-08-30 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
US20090258005A1 (en) 2007-05-29 2009-10-15 Trubion Pharmaceuticals Inc. Therapeutic compositions and methods
JP5122908B2 (ja) 2007-10-17 2013-01-16 日泉化学株式会社 自動車の内装用部材の取り付け構造
CA2730042A1 (en) 2008-07-07 2010-01-14 Athera Biotechnologies Ab New therapeutic and diagnostic methods for alzheimer's disease
WO2012010291A1 (en) 2010-07-21 2012-01-26 Athera Biotechnologies Ab Diagnostic and therapeutic methods and compositions for metabolic disease
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
BR112014002929A8 (pt) * 2011-08-09 2021-09-28 Athera Biotechnologies Ab Novos anticorpos contra fosforilcolina
JP6277126B2 (ja) 2011-08-09 2018-02-07 アセラ・バイオテクノロジーズ・アーベー ホスホリルコリン（ｐｃ）および／またはｐｃコンジュゲートに結合する抗体

Similar Documents

Publication Publication Date Title
JP2014525233A5 (enExample)
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP6843090B2 (ja) 血清アルブミンに結合するタンパク質
JP7195142B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2017508466A5 (enExample)
JP2011514150A5 (enExample)
JP2014529398A5 (enExample)
JP2017052784A5 (enExample)
JP2011526785A5 (enExample)
JP2018526981A5 (enExample)
JP2013538057A5 (enExample)
JP2015525211A5 (enExample)
JP2014534242A5 (enExample)
JP2015533795A5 (enExample)
JP2014526898A5 (enExample)
JP2015501814A5 (enExample)
JP2016512551A5 (enExample)
JP2014511179A5 (enExample)
JP2018521638A5 (enExample)
NZ598670A (en) Antibodies against glucagon receptor and their use
JP2018527919A5 (enExample)
JP2016503065A5 (enExample)
JP2015504306A5 (enExample)
RU2016100892A (ru) Антитела против tweakr и их применение
HRP20140244T1 (hr) Sastavi i metode za inhibiranje pdgfrbeta i vegf-a